DJIA 17,209.67 -70.07 -0.41%
NASDAQ 4,521.42 -58.37 -1.27%
S&P 500 1,995.45 -14.95 -0.74%
market minute promo

Chimerix (NASDAQ: CMRX)

26.36 -0.92 (-3.37%)

Quote as of


company name or ticker

Recent Quotes

CMRX $26.36 -3.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.09
Previous Close $27.28
Daily Range $26.32 - $27.19
52-Week Range $12.96 - $30.99
Market Cap $940.2M
P/E Ratio 389.71
Dividend (Yield) $0.00 (0.0%)
Volume 114,670
Average Daily Volume 403,642
Current FY EPS -$1.68

Sector

Industry

Chimerix (CMRX) Description

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157. Website: http://www.chimerix.com/

News & Commentary

Why Chimerix, Inc. Shares Took Off

Chimerix shares rally following the close of its share offering. Find out what shareholders should have their eyes on instead.

3 Biotech Breakout Charts That Could See More Upside

New Lifetime High Today: Chimerix (CMRX)

Chimerix (CMRX) in Focus: Stock Surges 11.8% - Tale of the Tape

InsiderInsights.com Daily Round Up 9/9/14: Republic Services, Intevac, Bob Evans And Advanced Draina

InsiderInsights.com Daily Round Up 9/9/14: Republic Services, Intevac, Bob Evans And Advanced Drainage Systems

Chimerix's (CMRX) CEO Presents at Morgan Stanley Healthcare Conference (Transcript)

Chimerix's (CMRX) CEO Presents at Morgan Stanley Healthcare Conference Call (Transcript)

Biopharmaceutical Stocks Stemline, Chimerix Climb Midday

Tuesday 9/9 Insider Buying Report: CMRX, ANAC

Chimerix Announces Brincidofovir Suggests Favorable Resistance Profile in Adenovirus, CMV

Infoblox Inc. (BLOX) Climbs On Earnings

See More CMRX News...